Verastem (VSTM) Non-cash Items (2011 - 2026)

Verastem (VSTM) recorded quarterly Non-cash Items of $855000.0 in Q1 2026, down 68.69% quarter-over-quarter from $2.7 million in Q4 2025, and down 28.27% on a YoY basis from $1.2 million in Q1 2025.

Verastem (VSTM) Non-cash Items (2011 - 2026) Analysis & Trends

Verastem's Non-cash Items history runs 16 years deep, the most recent figure standing at $855000.0 for Q1 2026.

  • In Q1 2026, Non-cash Items fell 28.27% year-over-year to $855000.0; the TTM figure through Mar 2026 stood at $855000.0 (down 28.27% YoY), while the FY2025 annual figure was $2.7 million, up 223.96% from the prior year.
  • Non-cash Items was $855000.0 for Q1 2026 at Verastem, down from $2.7 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $4.7 million in Q3 2025 to a low of $18000.0 in Q4 2022.
  • Historically, Non-cash Items has averaged $1.1 million across 5 years, with a median of $470000.0 in 2023.
  • The sharpest annual moves came in 2022 and 2025: Non-cash Items plunged 99.9% in 2022, then soared 26250.0% in 2025.
  • A 5-year view of Non-cash Items shows it stood at $18000.0 in 2022, then surged by 3005.56% to $559000.0 in 2023, then surged by 50.81% to $843000.0 in 2024, then surged by 223.96% to $2.7 million in 2025, then sank by 68.69% to $855000.0 in 2026.
  • The last three Non-cash Items figures came in at $855000.0 (Q1 2026), $2.7 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 855,000.00
Mar 31, 2026 855,000.00
Dec 31, 2025 2.73 Mn
Dec 31, 2025 2.73 Mn
Sep 30, 2025 4.74 Mn
Sep 30, 2025 4.74 Mn
Jun 30, 2025 397,000.00
Jun 30, 2025 397,000.00
Mar 31, 2025 1.19 Mn
Mar 31, 2025 1.19 Mn
Dec 31, 2024 843,000.00
Dec 31, 2024 843,000.00
Sep 30, 2024 18,000.00
Sep 30, 2024 18,000.00
Mar 31, 2024 4.54 Mn
Mar 31, 2024 4.54 Mn
Dec 31, 2023 559,000.00
Dec 31, 2023 559,000.00
Sep 30, 2023 470,000.00
Sep 30, 2023 470,000.00